The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy

C. Chiesa, K. Sjogreen Gleisner, G. Flux, J. Gear, S. Walrand, K. Bacher, U. Eberlein, E. P. Visser, N. Chouin, M. Ljungberg, M. Bardies, M. Lassmann, L. Strigari, M. W. Konijnenberg

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1783-1786
JournalEuropean Journal of Pediatrics
Volume44
Issue number11
DOIs
Publication statusPublished - May 24 2017

Cite this

Chiesa, C., Gleisner, K. S., Flux, G., Gear, J., Walrand, S., Bacher, K., Eberlein, U., Visser, E. P., Chouin, N., Ljungberg, M., Bardies, M., Lassmann, M., Strigari, L., & Konijnenberg, M. W. (2017). The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy. European Journal of Pediatrics, 44(11), 1783-1786. https://doi.org/10.1007/s00259-017-3707-3 [doi]